The importance of SLFN11 for drug sensitivity has recently been extended to Ewing's sarcomas [26], and to patient responses in ovarian, non-small cell lung and colorectal cancers [23, 24, 27]. This evidence concerns the gene SLFN11 and Ewing sarcoma.